Tom Rushmore

582 citations

14 papers · 485 indexed · h-index 13

Impact in

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Inflammatory mediators and NSAID effects
Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology

Papers in

Pharmacology 10
- Pharmacogenetics and Drug Metabolism 8
- Inflammatory mediators and NSAID effects 2
Biochemistry 2
- Eicosanoids and Hypertension Pharmacology 2

Co-authors: Mark T. Goldberg M. Anthony Hayes Jeffrey P. Jones Amit Ghoshal Danny Ghazarian V. Subrahmanyan E Farber Yulin Fang
Journals: Bioorganic & Medicinal Chemistry (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Tetrahedron Letters (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: United States Canada France

In The Last Decade

Tom Rushmore

14 papers receiving 468 citations

Peers

Countries citing papers authored by Tom Rushmore

Since Specialization

Citations

This map shows the geographic impact of Tom Rushmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Rushmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Rushmore more than expected).

Fields of papers citing papers by Tom Rushmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Rushmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Rushmore. The network helps show where Tom Rushmore may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tom Rushmore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tom Rushmore Line = papers co-authored together Tom Rushmore links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Discovery of selective glucocorticoid receptor modulator MK-5932 Bioorganic & Medicinal Chemistry ·Christopher J. Bungard, George D. Hartman, V.P. Vorob'yev, James J. Perkins, Chang Bai, Philip E. Brandish, Andrej Naglič, James C. Hershey, Azriel Schmidt, Yulin Fang, I Minchala-Avila Luis, Tom Rushmore, Charles D. Thompson, Robert Meißner	2011	16
2	CYP2C75-Involved Autoinduction of Metabolism in Rhesus Monkeys of Methyl 3-Chloro-3′-fluoro-4′-{(1 R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1′-biphenyl-2-carboxylate (MK-0686), a Bradykinin B1 Receptor Antagonist Journal of Pharmacology and Experimental Therapeutics ·Cuyue Tang, Brian Carr, Hyung-Ho Shin, Bennett Ma, P.C. Conor, Yuhsin Kuo, Sheva Putra Handi Aksan, Chan-Jong Lee, Karen Richards, ISOBEL MARGUERITE SUSON NGO, Edward J. Carlini, Christina N. Di Marco, Scott D. Kuduk, Nathan X. Yu, Conrad E. Raab, Tom Rushmore, Clay B. Frederick, Mark G. Bock, Thomayant Prueksaritanont	2008	6
3	Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9 Bioorganic & Medicinal Chemistry ·Michael R. Carey, Tom Rushmore, Rogatikh Na, Jeffrey P. Jones	2008	14
4	Cytochrome P450 2C9 Type II Binding Studies on Quinoline-4-Carboxamide Analogues Journal of Medicinal Chemistry ·Michael R. Carey, Jonathan L. Cape, Tom Rushmore, Rogatikh Na, Jeffrey P. Jones	2008	40
5	Diclofenac hydroxylation in monkeys: Efficiency, regioselectivity, and response to inhibitors Biochemical Pharmacology ·Cuyue Tang, Yulin Fang, Catherine Booth-Genthe, Yuhsin Kuo, Scott D. Kuduk, Tom Rushmore, Brian Carr	2006	14
6	Characterization of the Rhesus Monkey CYP3A64 Enzyme: Species Comparisons of CYP3A Substrate Specificity and Kinetics Using Baculovirus-Expressed Recombinant Enzymes Drug Metabolism and Disposition ·Brian Carr, I Minchala-Avila Luis, Yulin Fang, Ping Lu, A. David Rodrigues, Magang Shou, Tom Rushmore, Catherine Booth-Genthe	2006	48
7	An invasive cleavage assay for direct quantitation of specific RNAs Nature Biotechnology ·Peggy S. Eis, Marilyn C. Olson, Tsetska Takova, Michelle Curtis, Gelvez Munevar, W. P. Wallace, Hon S. Ip, 이재상, Ghazi, Hatim T. Allawi, W Janiak, Jeff G. Hall, Bhargavi Baljoshi, Tom Rushmore, Victor I. Lyamichev, Robert Kwiatkowski	2001	52
8	Syntheses of 5- and 6-[2,3]-dihydrobenzofuran β-amino acids Tetrahedron Letters ·Paul J. Coleman, John H. Hutchinson, C. A. HUNT, Ping Lü, Jea-Hyung Lim, Tom Rushmore	2000	14
9	Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174 Clinical Pharmacology & Therapeutics ·Jacqueline B. McCrea, Alastair E. Cribb, Tom Rushmore, Barbara A. Osborne, Lisa Gillen, Man-Wai Lo, Scott A. Waldman, T D Bjornsson, Stephen P. Spielberg, Melvyn Goldberg	1999	59
10	A mutation in CYP2C9 is responsible for decreased metabolism of losartan. Clinical Pharmacology & Therapeutics ·Stephen P. Spielberg, Jacqueline B. McCrea, Alastair E. Cribb, Tom Rushmore, Scott A. Waldman, Jimenez Ruiz Monica, Man-Wai Lo, Michael R. Goldberg	1996	23
11	Enantioselective activation of the peroxisome proliferator-activated receptor. Journal of Biological Chemistry ·Yves Boie, Mohammed Adam, Tom Rushmore, Brian P. Kennedy	1993	28
12	Analysis of the Upstream Elements of the Xenobiotic Compound-Inducible and Positionally Regulated Glutathione S-Transferase Ya Gene Molecular and Cellular Biology ·K. Eric Paulson, James Darnell, Tom Rushmore, Cecil B. Pickett	1990	16
13	Probable free radical effects on rat liver nuclei during early hepatocarcinogenesis with a choline-devoid low methionine diet. PubMed ·Tom Rushmore, Danny Ghazarian, V. Subrahmanyan, E Farber, Amit Ghoshal	1987	57
14	Inhibition of hepatocarcinogenic responses to 1,2-dimethylhydrazine by diallyl sulfide, a component of garlic oil Carcinogenesis ·M. Anthony Hayes, Tom Rushmore, Mark T. Goldberg	1987	98

About Tom Rushmore

Tom Rushmore is a scholar working on Pharmacology, Biochemistry, Biochemistry, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 14 papers that have together received 485 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Inflammatory mediators and NSAID effects (2 papers), Chemotherapy-induced organ toxicity mitigation (1 paper), Garlic and Onion Studies (1 paper), Carcinogens and Genotoxicity Assessment (1 paper) and Glutathione Transferases and Polymorphisms (1 paper). The work is most often cited by research in Pharmacology (191 citations), Biochemistry (45 citations), Oncology (126 citations), Clinical Biochemistry (22 citations) and Biochemistry (17 citations). Tom Rushmore has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Mark T. Goldberg, M. Anthony Hayes, Jeffrey P. Jones, Amit Ghoshal, Danny Ghazarian, V. Subrahmanyan, E Farber, Yulin Fang, Scott A. Waldman and Man-Wai Lo. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Clinical Pharmacology & Therapeutics, Journal of Pharmacology and Experimental Therapeutics, Tetrahedron Letters and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact